This research demonstrates that within-trial prognostic adjustments can mimic maximum likelihood estimation, highlighting implications for randomized trials.
Adjustment for ``super'' or ``prognostic'' composite covariates has become more popular in randomized trials recently. These prognostic covariates are often constructed from historical data by fitting a predictive model of the outcome on the raw covariates. A natural question that we have been asked by applied researchers is whether this can be done without the historical data: can the prognostic covariate be constructed or derived from the trial data itself, possibly using different folds of the data, before adjusting for it? Here we clarify that such ``within-trial'' prognostic adjustment is nothing more than a form of targeted maximum likelihood estimation (TMLE), a well-studied procedure for optimal inference. We demonstrate the equivalence with a simulation study and discuss the pros and cons of within-trial prognostic adjustment (standard efficient estimation) relative to standard TMLE and standard prognostic adjustment with historical data.
No takes yet. Share an insight, caveat, or question.
Højbjerre‐Frandsen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: